Related references
Note: Only part of the references are listed.Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma et al.
CLINICAL CANCER RESEARCH (2019)
Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
Eun-Ah Bae et al.
CANCER RESEARCH (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma
Yuko Miyasato et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2018)
A Putative Association of Interleukin-10 Promoter Polymorphisms with Cardiovascular Disease
Shams Tabrez et al.
IUBMB LIFE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Detection of immune responses after immunotherapy in glioblastoma using PET and MRI
Joseph P. Antonios et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Purushottam Lamichhane et al.
CANCER RESEARCH (2017)
Covalent nano delivery systems for selective imaging and treatment of brain tumors
Julia Y. Ljubimova et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
M. B. Atkins et al.
ANNALS OF ONCOLOGY (2017)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models
Marine M. Leblond et al.
ONCOIMMUNOLOGY (2016)
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2016)
Tumor infiltrating immune cells in gliomas and meningiomas
Patricia Domingues et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
A Breakthrough: Macrophage-Directed Cancer Immunotherapy
Charles D. Mills et al.
CANCER RESEARCH (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Trafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier
Roberto Villasenor et al.
SCIENTIFIC REPORTS (2016)
PD-1 Blockade Expands Intratumoral Memory T Cells
Antoni Ribas et al.
CANCER IMMUNOLOGY RESEARCH (2016)
MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain
Rameshwar Patil et al.
ACS NANO (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
LRP-1-mediated intracellular antibody delivery to the Central Nervous System
Xiaohe Tian et al.
SCIENTIFIC REPORTS (2015)
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice
Judith T. Murphy et al.
BLOOD (2014)
Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2014)
Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2014)
Current approaches to the treatment of metastatic brain tumours
Taofeek K. Owonikoko et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity
William L. Redmond et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Julia Y. Ljubimova et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers
Hui Ding et al.
BIOMATERIALS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation
Allison L. Bayer et al.
IMMUNOLOGIC RESEARCH (2013)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
IL-4 in the Brain: A Cytokine To Remember
Sachin P. Gadani et al.
JOURNAL OF IMMUNOLOGY (2012)
Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
James M. Markert et al.
JOURNAL OF VIROLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Mouse and human neutrophils induce anaphylaxis
Friederike Joensson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis
Marat V. Khodoun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Association of interleukin-10 gene variation with breast cancer prognosis
Armin Gerger et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release
Hui Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glioblastoma multiforme: a review of therapeutic targets
Okezie O. Kanu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Antitumor activity of anti-CTLA-4 monoclonal antibody (mAb) in combination with ixabepilone in preclinical tumor models
M. N. Jure-Kunkel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
New developments in FcεRI regulation, function and inhibition
Stefan Kraft et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Share Paper
